Peginterferon for children with chronic hepatitis B
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests if peginterferon alfa-2b can help children with chronic hepatitis B achieve a functional cure. If your child has had hepatitis B for a while and still has the virus in their blood, this study might be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 17 years old.
- Your child must have a positive HBV DNA test, meaning the virus is active.
- Your child must test positive for hepatitis B surface antigen (HBsAg) above a certain level.
- You and your child must agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining peginterferon alpha-2b with a nucleoside analog can lower liver cancer risk in people with chronic hepatitis B who have a family history of liver cancer. It compares the combination therapy to nucleoside analog alone.
This study looks at how well antiviral medicines work for children with long-term hepatitis B. It may help doctors find the best way to treat or stop treatment for kids who have had the virus for a while.
This trial studies whether pegylated interferon can help people with inactive chronic hepatitis B stay stable or improve outcomes. You may qualify if your virus levels and liver blood tests are currently low and you’ve never used antiviral treatments.
This study tests whether additional peginterferon treatment can further reduce the virus in the liver for people with chronic hepatitis B who have already reached a clinical cure. You would need to have two liver biopsies to check the virus levels.
This trial compares two treatments for young children (ages 3–6) with active chronic hepatitis B: entecavir alone versus entecavir plus a short course of pegylated interferon. The goal is to see if adding interferon helps control the infection better.
This study tests whether a long-acting interferon medication can help people with chronic hepatitis B who have already received interferon treatment clear the hepatitis B virus more completely. It's designed for patients whose virus levels dropped significantly during their first treatment but haven't gone away.
Hear when a new HBV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.